Publications by authors named "Candis Morrison"

Claim this Profile
C
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.
Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, James D Phelan, Da Wei Huang, Candis Morrison

N Engl J Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab: A review of current indications and future directions.
Elizabeth Hill, Candis Morrison, Dickran Kazandjian

Semin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical guidance for new multiple myeloma treatment regimens: A nursing perspective.
Monica Epstein, Candis Morrison

Semin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial.
Dickran Kazandjian, Elizabeth Hill, Alexander Dew, Candis Morrison, Joseph Roswarski

JAMA Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of F-FDG-PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma: time to move forward.
Elizabeth Hill, Esther Mena, Candis Morrison, Alexander Dew, Peter Choyke

Br J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.
Dickran Kazandjian, Alexander Dew, Elizabeth Hill, Elizabeth Gil Ramirez, Candis Morrison

Oncologist· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models.
Elizabeth Hill, Alexander Dew, Candis Morrison, Constance Yuan, Maryalice Stetler-Stevenson

JAMA Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma.
Sham Mailankody, Dickran Kazandjian, Neha Korde, Mark Roschewski, Elisabet Manasanch, Candis Morrison

Blood Adv· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma.
Neha Korde, Mark Roschewski, Adriana Zingone, Mary Kwok, Elisabet E Manasanch, Candis Morrison

JAMA Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual presentation of Lyme disease: Horner syndrome with negative serology.
Candis Morrison, Ari Seifter, John N Aucott

J Am Board Fam Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic challenges of early Lyme disease: lessons from a community case series.
John Aucott, Candis Morrison, Beatriz Munoz, Peter C Rowe, Alison Schwarzwalder

BMC Infect Dis· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement.
Yvette L Kasamon, Richard J Jones, Steven Piantadosi, Richard F Ambinder, Ross A Abrams, Candis Morrison

Biol Blood Marrow Transplant· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features--correlation of clinical improvement with tumor response.
Rodrigo Erlich, Candis Morrison, Bong Kim, Mark R Gilbert, Saadah Alrajab

Cancer Invest· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and management of delirium in the critically ill patient with cancer.
Candis Morrison

AACN Clin Issues· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis